| Clinical and economic burden of adverse drug reactions J Sultana, P Cutroneo, G Trifirò Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S73-S77, 2013 | 676 | 2013 |
| Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis S Crisafulli, J Sultana, A Fontana, F Salvo, S Messina, G Trifirò Orphanet journal of rare diseases 15, 1-20, 2020 | 382 | 2020 |
| Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study G Trifirò, P Morabito, L Cavagna, C Ferrajolo, S Pecchioli, M Simonetti, ... Annals of the rheumatic diseases 72 (5), 694-700, 2013 | 346 | 2013 |
| Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project PM Coloma, MJ Schuemie, G Trifiro, R Gini, R Herings, J Hippisley‐Cox, ... Pharmacoepidemiology and drug safety 20 (1), 1-11, 2011 | 324 | 2011 |
| Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care G Mazzaglia, LG Mantovani, MCJM Sturkenboom, A Filippi, G Trifiro, ... Journal of hypertension 23 (11), 2093-2100, 2005 | 286 | 2005 |
| Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017 | 257 | 2017 |
| Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ... Blood advances 3 (8), 1197-1210, 2019 | 242 | 2019 |
| The economic burden of preventable adverse drug reactions: a systematic review of observational studies D Formica, J Sultana, PM Cutroneo, S Lucchesi, R Angelica, S Crisafulli, ... Expert opinion on drug safety 17 (7), 681-695, 2018 | 221 | 2018 |
| Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? G Trifirò, A Pariente, PM Coloma, JA Kors, G Polimeni, ... Pharmacoepidemiology and drug safety 18 (12), 1176-1184, 2009 | 221 | 2009 |
| Clinically significant drug interactions with newer antidepressants E Spina, G Trifirò, F Caraci CNS drugs 26, 39-67, 2012 | 210 | 2012 |
| Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case–control study G Trifiro, G Gambassi, EF Sen, AP Caputi, V Bagnardi, J Brea, ... Annals of internal medicine 152 (7), 418-425, 2010 | 199 | 2010 |
| Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines J Sultana, PM Cutroneo, S Crisafulli, G Puglisi, G Caramori, G Trifirò Drug safety 43, 691-698, 2020 | 196 | 2020 |
| The EU-ADR corpus: annotated drugs, diseases, targets, and their relationships EM Van Mulligen, A Fourrier-Reglat, D Gurwitz, M Molokhia, A Nieto, ... Journal of biomedical informatics 45 (5), 879-884, 2012 | 193 | 2012 |
| Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems G Trifiro, E Spina Current drug metabolism 12 (7), 611-620, 2011 | 193 | 2011 |
| Challenges for drug repurposing in the COVID-19 pandemic era J Sultana, S Crisafulli, F Gabbay, E Lynn, S Shakir, G Trifirò Frontiers in pharmacology 11, 588654, 2020 | 162 | 2020 |
| Antibiotic use in children–a cross-national analysis of 6 countries I Youngster, J Avorn, V Belleudi, A Cantarutti, J Díez-Domingo, ... The Journal of pediatrics 182, 239-244. e1, 2017 | 152 | 2017 |
| Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture? PM Coloma, G Trifirò, V Patadia, M Sturkenboom Drug safety 36, 183-197, 2013 | 150 | 2013 |
| Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study J Holstiege, T Schink, M Molokhia, G Mazzaglia, F Innocenti, A Oteri, ... BMC pediatrics 14, 1-10, 2014 | 144 | 2014 |
| Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? G Trifirò, PM Coloma, PR Rijnbeek, S Romio, B Mosseveld, D Weibel, ... Journal of internal medicine 275 (6), 551-561, 2014 | 142 | 2014 |
| High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA) G Onder, S Bonassi, AM Abbatecola, P Folino-Gallo, F Lapi, N Marchionni, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2014 | 141 | 2014 |
